Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$303K Buy
8,689
+6,909
+388% +$242K 0.08% 63
2020
Q2
$55K Sell
1,780
-316
-15% -$10.7K 0.02% 92
2020
Q1
$65K Buy
2,096
+248
+13% +$8.45K 0.02% 89
2019
Q4
$69K Sell
1,848
-950
-34% -$33.8K 0.02% 94
2019
Q3
$95K Buy
2,798
+1,150
+70% +$41.8K 0.03% 92
2019
Q2
$68K Buy
1,648
+191
+13% +$7.58K 0.02% 106
2019
Q1
$59K Hold
1,457
0.02% 85
2018
Q4
$60K Hold
1,457
0.03% 81
2018
Q3
$61K Sell
1,457
-1,923
-57% -$74K 0.02% 77
2018
Q2
$116K Buy
3,380
+430
+15% +$14.7K 0.04% 79
2018
Q1
$99K Buy
2,950
+1,456
+97% +$50.1K 0.06% 69
2017
Q4
$51K Buy
+1,494
New +$50.9K 0.03% 58

Other funds holding PFE

Price Wealth's PFE Position: Q3 2020 in Review

Price Wealth increased its Pfizer (PFE) stake by 388% in Q3 2020, buying an estimated $242K and bringing the position to 8,689 shares worth $303K. The position accounts for 0.08% of the portfolio, ranked #63.

Price Wealth first reported a position in PFE in Q4 2017 and has held it in 12 quarters since. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

  • Price Wealth held 8,689 shares of Pfizer worth $303K as of Q3 2020.
  • Price Wealth bought 6,909 Pfizer shares in Q3 2020, an estimated $242K.
  • Pfizer made up 0.08% of Price Wealth's portfolio in Q3 2020, its #63 holding.
  • Price Wealth first reported a position in Pfizer in Q4 2017 and has held it in 12 quarters since.
  • 2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Price Wealth's 13F filing for Q3 2020, filed 22 Oct 2020.